Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 514Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Myelodysplastic Syndromes 234Lymphoma, Non-Hodgkin 173Lymphoma 162Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Hematologic Neoplasms 133Multiple Myeloma 121Lymphoma, Follicular 120Lymphoma, Large B-Cell, Diffuse 119Lymphoma, Mantle-Cell 118Recurrence 115Hodgkin Disease 99Burkitt Lymphoma 99Lymphoma, B-Cell, Marginal Zone 98Congenital Abnormalities 78Leukemia, Myelomonocytic, Chronic 77Leukemia, Myeloid, Chronic-Phase 68Neoplasms 67Myeloproliferative Disorders 66Lymphoma, Large-Cell, Immunoblastic 64Blast Crisis 59Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Waldenstrom Macroglobulinemia 53Primary Myelofibrosis 53Lymphoma, T-Cell, Cutaneous 52Leukemia, Myeloid, Accelerated Phase 50Neoplasms, Plasma Cell 48

Interventions

ceftolozane, tazobactam drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gram-Negative Bacterial Infections × Other hematologic neoplasm × Clear all
NCT04673175 2026-01-21

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Weill Medical College of Cornell University

Phase 4 Terminated
17 enrolled 20 charts
Other hematologic neoplasm

Pneumonia, Pseudomonas Infections, Bacteremia, Gram-Negative Bacterial Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡